Molecular Data
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Molecular Data generated cash of -$234,048,000, which is less than the previous year. Cash used in financing activities reached the amount of $529,143,000 last year. Net change in cash is therefore -$46,086,000.

Cash Flow

Molecular Data Inc. (NASDAQ:MKD): Cash Flow
2016 -145.59M -2.64M 173.30M
2017 -186.70M -3.98M 262.84M
2018 -134.63M -2.24M 37.33M
2019 -95.82M -1.82M 149.39M
2020 -234.04M -320.30M 529.14M

MKD Cash Flow Statement (2016 – 2020)

2020 2019 2018 2017 2016
Cash at beginning of period
57.67M6.47M106.02M33.85M8.79M
Operating activities
Net income
-328.03M-193.54M-254.63M-107.80M-113.93M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
1.72M3.05M2.43M1.48M978K
Stock-based compensation expense
44.52M38.99M124.02M00
Deferred income tax benefit 44.52M38.99M124.02M00
Changes in operating assets and liabilities:
Accounts receivable, net
13.15M16.02M13.42M15.15M-44.65M
Inventories
1.53M2.90M11.94M-3.23M-14.8M
Accounts payable
11.34M206.20M14M-26.48M33.05M
Cash generated by operating activities
-234.04M-95.82M-134.63M-186.70M-145.59M
Investing activities
Purchases Of Investments
-337.03M00-2.05M0
Investments In Property Plant And Equipment
-116K-1.82M-2.24M-1.93M-2.64M
Acquisitions Net
00000
Cash generated by investing activities
-320.30M-1.82M-2.24M-3.98M-2.64M
Financing activities
Common Stock Issued
419.95M069.90M179.95M92.02M
Payments for dividends
00-6.81M-370K0
Repurchases of common stock
00-6.81M-370K0
Repayments of term debt
00-905.57M0-633.47M
Cash used in financing activities
529.14M149.39M37.33M262.84M173.30M
Net Change In Cash
-46.08M51.19M-99.54M72.16M25.06M
Cash at end of period
11.58M57.67M6.47M106.02M33.85M
Data sourceData source